SirYus technology opens the way for novel solutions to assess receivers reactions towards their transplant in order to drastically reduce rejection.
Innobiochips has developed a biochip dedicated HLA markers (cell surface proteins) and HLA antibodies detection.
Based on SirYus biochips (96 antigens of Class I and 62 of Class II), this HLA immunoassay specifically identifiesanti-HLA antibodies to predict compatibility and avoid acute rejection.
This SirYus technology application is being developed with Itwo german partners.
This solutions enables to automate a today partially manual process and to yield more reliable and accurate biological data.